1. Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond

   • Jun H. Choi
   • James M. Bogenberger
   • Raoul Tibes

   Review Article 21 April 2020 Pages: 147 - 162

   

2. Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer

   • Ramesh K. Ramanathan
   • Daniel D. Von Hoff
   • Klaus Mross

   Original Research Article Open access 27 October 2020 Pages: 163 - 174

   

3. Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study

   • Yuqing Lou
   • Jianlin Xu
   • Baohui Han

   Original Research Article 13 March 2020 Pages: 175 - 184

   

4. Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study

   • Seonggyu Byeon
   • Jung Yong Hong
   • Seung Tae Kim

   Original Research Article 27 February 2020 Pages: 185 - 192

   

5. Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

   • Tomas Buchler
   • Igor Kiss
   • Bohuslav Melichar

   Original Research Article 12 February 2020 Pages: 193 - 201

   

6. Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients

   • Jinchul Kim
   • Seonggyu Byeon
   • Seung Tae Kim

   Original Research Article 20 April 2020 Pages: 203 - 209

   

7. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma

   • Iris Y. Sheng
   • Claudia Marcela Diaz-Montero
   • Moshe C. Ornstein

   Original Research Article 23 March 2020 Pages: 211 - 220

   

8. Genomic Alterations and MYD88^MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib

   • Shiyu Jiang
   • Yan Qin
   • Yuankai Shi

   Original Research Article 01 April 2020 Pages: 221 - 230

   

9. Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model

   • Haley E. Ramsey
   • Aram Oganesian
   • Michael R. Savona

   Original Research Article Open access 28 March 2020 Pages: 231 - 240

   

10. Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

    • Yong-Hee Cho
    • Myeong Geun Choi
    • Chang-Min Choi

    Short Communication 13 April 2020 Pages: 241 - 247